Tilray Brands, Inc. (TLRY.TO)
CAD 1.69
(-3.98%)
CAD 1.69
(-3.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.22 Billion USD | -1.99% |
| 2022 | 4.3 Billion USD | -20.96% |
| 2021 | 5.44 Billion USD | -9.55% |
| 2020 | 6.02 Billion USD | 234.51% |
| 2019 | 1.8 Billion USD | -0.19% |
| 2018 | 1.8 Billion USD | 77.08% |
| 2017 | 1.01 Billion USD | 334.5% |
| 2016 | 234.54 Million USD | 743.18% |
| 2015 | 27.81 Million USD | 141.87% |
| 2014 | 11.5 Million USD | 6690.7% |
| 2013 | 169.35 Thousand CAD | -40.0% |
| 2012 | 282.27 Thousand USD | -18.0% |
| 2011 | 344.22 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.26 Billion USD | 2.21% |
| 2023 FY | 4.22 Billion USD | -1.99% |
| 2023 Q4 | 4.22 Billion USD | 0.21% |
| 2023 Q3 | 4.21 Billion USD | -2.72% |
| 2023 Q2 | 4.33 Billion USD | -1.63% |
| 2023 Q1 | 4.4 Billion USD | 2.21% |
| 2022 Q4 | 4.3 Billion USD | -1.57% |
| 2022 FY | 4.3 Billion USD | -20.96% |
| 2022 Q1 | 5.59 Billion USD | 2.62% |
| 2022 Q2 | 5.47 Billion USD | -2.11% |
| 2022 Q3 | 4.37 Billion USD | -20.07% |
| 2021 Q2 | 5.76 Billion USD | -3.72% |
| 2021 Q1 | 5.98 Billion USD | -0.65% |
| 2021 Q4 | 5.44 Billion USD | -6.35% |
| 2021 Q3 | 5.81 Billion USD | 0.97% |
| 2021 FY | 5.44 Billion USD | -9.55% |
| 2020 Q3 | 2.2 Billion USD | 1.7% |
| 2020 Q2 | 2.16 Billion USD | 13.71% |
| 2020 Q1 | 1.9 Billion USD | 5.69% |
| 2020 FY | 6.02 Billion USD | 234.51% |
| 2020 Q4 | 6.02 Billion USD | 173.68% |
| 2019 FY | 1.8 Billion USD | -0.19% |
| 2019 Q1 | 1.82 Billion USD | 0.9% |
| 2019 Q3 | 1.94 Billion USD | 3.7% |
| 2019 Q2 | 1.87 Billion USD | 2.87% |
| 2019 Q4 | 1.8 Billion USD | -7.26% |
| 2018 FY | 1.8 Billion USD | 77.08% |
| 2018 Q4 | 1.8 Billion USD | 15.58% |
| 2018 Q3 | 1.56 Billion USD | -1.21% |
| 2018 Q2 | 1.58 Billion USD | 26.26% |
| 2018 Q1 | 1.25 Billion USD | 22.83% |
| 2017 Q3 | 668.99 Million USD | 95.84% |
| 2017 Q4 | 1.01 Billion USD | 52.33% |
| 2017 FY | 1.01 Billion USD | 334.5% |
| 2017 Q1 | 262.3 Million USD | 11.84% |
| 2017 Q2 | 341.59 Million USD | 30.23% |
| 2016 FY | 234.54 Million USD | 743.18% |
| 2016 Q4 | 234.54 Million USD | 52.48% |
| 2016 Q3 | 153.81 Million USD | 48.98% |
| 2016 Q1 | 63 Million USD | 126.5% |
| 2016 Q2 | 103.24 Million USD | 63.87% |
| 2015 FY | 27.81 Million USD | 141.87% |
| 2015 Q4 | 27.81 Million USD | 28.78% |
| 2015 Q3 | 21.59 Million USD | 100.93% |
| 2015 Q2 | 10.75 Million USD | -1.88% |
| 2015 Q1 | 10.95 Million USD | -4.73% |
| 2014 FY | 11.5 Million USD | 6690.7% |
| 2014 Q4 | 11.5 Million USD | -0.72% |
| 2014 Q3 | 11.58 Million USD | 7369.4% |
| 2014 Q2 | 155.08 Thousand USD | -8.43% |
| 2014 Q1 | 169.35 Thousand USD | -32.28% |
| 2013 Q2 | 273.76 Thousand USD | -3.01% |
| 2013 Q1 | 282.27 Thousand USD | -2.28% |
| 2013 FY | 169.35 Thousand CAD | -40.0% |
| 2013 Q4 | 250.06 Thousand USD | 0.79% |
| 2013 Q3 | 248.09 Thousand USD | -9.38% |
| 2012 FY | 282.27 Thousand USD | -18.0% |
| 2012 Q1 | 344.22 Thousand USD | -1.39% |
| 2012 Q4 | 288.86 Thousand USD | -5.84% |
| 2012 Q3 | 306.77 Thousand USD | -10.91% |
| 2012 Q2 | 344.34 Thousand USD | 0.03% |
| 2011 FY | 344.22 Thousand USD | 0.0% |
| 2011 Q2 | 141.7 Thousand USD | 0.0% |
| 2011 Q4 | 349.07 Thousand USD | -4.88% |
| 2011 Q3 | 366.96 Thousand USD | 158.96% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | -403.374% |
| Avicanna Inc. | 21.97 Million CAD | -19114.62% |
| Avant Brands Inc. | 82.55 Million CAD | -5013.946% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -11403.015% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -17062.635% |
| Knight Therapeutics Inc. | 945.49 Million CAD | -346.504% |
| MediPharm Labs Corp. | 63.93 Million CAD | -6502.851% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | -1314.506% |
| Canopy Growth Corporation | 1.3 Billion CAD | -224.661% |
| Willow Biosciences Inc. | 6.67 Million CAD | -63164.873% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | -1511.913% |